We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
MCMC
1
Matrix Capital Management Company
New Hampshire
$30.9M
NMC
2
NEA Management Company
Maryland
$13.5M
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$12.6M -$696K -1,235,269 -7%
LFCM
4
Long Focus Capital Management
Puerto Rico
$9.58M +$633K +1,123,757 +10%
BBA
5
Baker Bros. Advisors
New York
$8.7M
PHS
6
PFM Health Sciences
California
$8.27M
MAM
7
MPM Asset Management
Massachusetts
$4.41M -$412K -731,640 -12%
MB
8
MPM BioImpact
Massachusetts
$4.04M
Bank of America
9
Bank of America
North Carolina
$3.73M +$467 +829 +0%
TCM
10
Tang Capital Management
California
$3.48M -$440K -779,716 -15%
Citadel Advisors
11
Citadel Advisors
Florida
$2.7M -$84.6K -150,045 -4%
RSCM
12
Rock Springs Capital Management
Maryland
$1.92M -$204K -362,377 -13%
Morgan Stanley
13
Morgan Stanley
New York
$1.55M -$53.4K -94,688 -5%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$1.37M
SP
15
Syncona Portfolio
Guernsey
$1.09M
Renaissance Technologies
16
Renaissance Technologies
New York
$1.09M +$193K +342,379 +33%
JP Morgan Chase
17
JP Morgan Chase
New York
$736K -$58.2K -103,193 -10%
RG
18
Redmile Group
California
$567K
GCP
19
GSA Capital Partners
United Kingdom
$403K +$287K +508,808 New
AI
20
Acuitas Investments
Washington
$380K +$14 +25 +0%
Millennium Management
21
Millennium Management
New York
$350K +$79.5K +140,971 +47%
RG
22
Rathbones Group
United Kingdom
$343K
DCM
23
DAFNA Capital Management
California
$278K
KCFA
24
Key Client Fiduciary Advisors
New Jersey
$267K +$11.4K +20,295 +6%
State Street
25
State Street
Massachusetts
$242K +$3.52K +6,235 +2%